7.19
price down icon1.91%   -0.14
after-market Dopo l'orario di chiusura: 7.27 0.08 +1.11%
loading

Athira Pharma Inc Azioni (ATHA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
14.90%
3.661
4.302 17.92 22.15 21.24
Costs And Expenses
23.54%
7.291
9.536 29.62 28.03 27.69
Operating Income/Loss
23.54%
-7.291
-9.536 -29.62 -28.03 -27.69
Income/Loss From Continuing Operations Before Tax
20.26%
-7.291
-9.143 -29.62 -26.86 -26.34
Income/Loss From Continuing Operations After Tax
23.81%
-6.966
-9.143 -28.74 -26.86 -26.34
Net Income/Loss
23.81%
-6.966
-9.143 -28.74 -26.86 -26.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
39.09
39.04 38.52 38.38 38.32
Diluted Average Shares
0.13%
39.09
39.04 38.52 38.38 38.32
Basic Earnings Per Share
21.74%
-0.18
-0.23 -0.75 -0.70 -0.69
Diluted Earnings Per Share
21.74%
-0.18
-0.23 -0.75 -0.70 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.63
price down icon 0.80%
$107.39
price up icon 4.56%
$105.92
price down icon 4.21%
$98.85
price down icon 1.23%
biotechnology ONC
$320.37
price down icon 4.04%
$170.27
price down icon 3.26%
Capitalizzazione:     |  Volume (24 ore):